A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2011
11/17/2011	WO2011121250A3 Cosmetic and pharmaceutical composition comprising n-acetylglucosamine-6-phosphate
11/17/2011	WO2011119605A3 Morphinane derivatives containing a carboxamide group as opioid receptor ligands
11/17/2011	WO2011113507A3 Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
11/17/2011	WO2011085013A3 Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
11/17/2011	WO2011079261A3 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
11/17/2011	WO2011078590A3 Ultraviolet protection composition comprising a blt2 inhibitor
11/17/2011	WO2011074921A3 Composition for alleviating atopic dermatitis and a preparation method of the same
11/17/2011	WO2011061252A3 Combination of alpha- 2 adrenergic receptor agonist and non-steroidal anti - inflammatory agent for treating or preventing an inflammatory skin disorder
11/17/2011	WO2010034917A3 Monoester of n-undecylenoyl phenylalanine and polyol, method for preparing same, and use of said esters as a skin lightening agent
11/17/2011	US20110282267 Fibroblast growth factor-9 promotes hair follicle regeneration after wounding
11/17/2011	US20110281951 Compositions and methods for treating amyloidosis
11/17/2011	US20110281949 Methods and compositions for treating neuronal damage and modulating transient receptor potential channels
11/17/2011	US20110281948 Cosmetic and pharmaceutical formulations of calixarene molecules
11/17/2011	US20110281947 Methods of administering diclofenac compositions for treating photodamaged skin
11/17/2011	US20110281941 Combination of lycopene, polyphenol, and vitamins for the care of keratin materials
11/17/2011	US20110281897 Heterocyclic compounds and their uses
11/17/2011	US20110281896 Optically pure quinazoline compounds
11/17/2011	US20110281891 N-hydroxyamide derivatives and use thereof
11/17/2011	US20110281885 Therapeutic agents useful for treating pain
11/17/2011	US20110281884 Fused derivatives as pi3kdelta inhibitors
11/17/2011	US20110281879 Sulfonyl containing compounds as cysteine protease inhibitors
11/17/2011	US20110281878 INHIBITORS OF p38
11/17/2011	US20110281870 Novel substituted octahydrocyclopenta[c]pyrrol-4-amines as calcium channel blockers
11/17/2011	US20110281859 Novel heterocyclic compounds as metap-2 inhibitors
11/17/2011	US20110281846 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
11/17/2011	US20110281844 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications
11/17/2011	US20110281843 Substituted indazole derivatives active as kinase inhibitors
11/17/2011	US20110281841 Kinase Inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281837 3-substituted-6-aryl pyridines
11/17/2011	US20110281836 Silent desensitizers of neuronal NACHR and methods of use thereof
11/17/2011	US20110281831 Novel dermaceutical cream made using sodium fusidate, antifungals and steroids
11/17/2011	US20110281830 Novel dermaceutical cream made using sodium fusidate and steroids
11/17/2011	US20110281827 Compositions, gels and foams with rheology modulators and uses thereof
11/17/2011	US20110281822 Aromatic compounds having sphingosine-1-phosphonate (s1p) receptor activity
11/17/2011	US20110281819 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
11/17/2011	US20110281812 Compounds
11/17/2011	US20110281799 Vascular Endothelial Growth Factor D (VEGF-D) Antibodies and Vectors, and Methods of Uses
11/17/2011	US20110280960 Thick pine needle extract composition for capsulation
11/17/2011	US20110280951 Composition from sphaeranthus indicus and garcinia mangostana for the control of metabolic syndrome
11/17/2011	US20110280933 Epicatechin compositions and methods
11/17/2011	US20110280932 Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent
11/17/2011	US20110280928 Wound Care Device Having Fluid Transfer Properties
11/17/2011	US20110280927 Composition and dressing with nitric oxide
11/17/2011	US20110280926 Wound dressing
11/17/2011	US20110280919 Reinforced Absorbable Synthethic Matrix for Hemostatic Applications
11/17/2011	US20110280882 Leukolectins and uses thereof
11/17/2011	US20110280878 Substance specific to human pd-1
11/17/2011	US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines
11/17/2011	US20110280872 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/17/2011	US20110280858 Treatment of wounds
11/17/2011	US20110280853 Compositions and methods for treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
11/17/2011	US20110280845 Treatment of rheumatoid arthritis using placental stem cells
11/17/2011	US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation
11/17/2011	US20110280831 Combinations comprising methotrexate and dhodh inhibitors
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280829 Low Molecular Weight Sulphated Polysaccharides as Candidates for Anti-Angiogenic Therapy
11/17/2011	US20110280800 Il-1 binding proteins
11/17/2011	DE102010022174A1 Neue Darreichungsformen für Cineol New forms of cineole
11/17/2011	DE102010020567A1 Metallkomplexe Metal complexes
11/17/2011	CA2835596A1 Benzo- or pyrido-imidazole derivative
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386546A1 Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same
11/16/2011	EP2386309A1 Bulbine frutescens gel
11/16/2011	EP2086552B1 Azithromycin for the treatment of nodular acne
11/16/2011	EP2044952B1 Use of the pedf factor to induce cell regeneration
11/16/2011	EP1855692B1 Compositions for treating skin diseases characterised by exudation of serum proteins
11/16/2011	CN1931193B Medicine for treating various types of noxious sore, angiitis and stomatocace
11/16/2011	CN102245622A Novel aryl C-xyloside compounds, and cosmetic use
11/16/2011	CN102245205A Methods to reduce B-helper T cells to treat autoimmune diseases
11/16/2011	CN102245188A Compositions for the prophylaxis and treatment of dermatological/mucosal diseases, and uses thereof
11/16/2011	CN102245177A Oral composition
11/16/2011	CN102245169A Salicylic acid composition
11/16/2011	CN102242154A Liquid fermentation method for producing paecilomyces cicadae mycelia and application of culture product
11/16/2011	CN102242152A Humic acid active component and preparation method, application and pharmaceutical composition thereof
11/16/2011	CN102242079A Medium for producing Paecilomyces cicadae spore, culture method thereof, culture product thereof and application thereof
11/16/2011	CN102242070A Method for artificially culturing paecilomyces cicadae and application of culturing product thereof
11/16/2011	CN102242069A Paecilomycescicadae (Miq.)Samson and application thereof
11/16/2011	CN102242027A Ginseng cosmetic fancy soap
11/16/2011	CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
11/16/2011	CN102240390A Medicament for treating alopecia areata
11/16/2011	CN102240354A Chinese medicine prescription for treating skin ulcer and preparation method thereof
11/16/2011	CN102240343A Environment-friendly preparation method for high-ester catechin tea polyphenol
11/16/2011	CN102240337A Formulas of internal medicine and external medicine for treating leucoderma
11/16/2011	CN102240336A Chinese medicinal composition for treating psoriasis
11/16/2011	CN102240333A Hair growth medicament composition
11/16/2011	CN102240331A Ointment mainly for treating rheumatoid arthritis
11/16/2011	CN102240317A Extraction process for preparing total flavones and chlorogenic acid from traditional Chinese medicine eucommia leaf
11/16/2011	CN102240316A Method for extracting anthocyanin containing extract from cowberry
11/16/2011	CN102240306A Process for extracting proanthocyanidins from pine cone shells
11/16/2011	CN102240305A Application of spirulina in preparation of medicine for treating skin depigmentation
11/16/2011	CN102240300A Method for producing biologically active products
11/16/2011	CN102240285A Amoxicillin and potassium clavulanate tablet for dogs and cats, and its preparation method and application
11/16/2011	CN102240268A Sustained/controlled release microsphere of biological extract Genipin cross-linked chitosan coated stilbene compound and preparation method thereof
11/16/2011	CN102018782B Compound cutch sarcogenic oil and preparation method thereof

1 ... 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 ... 1065